Publicacions - Fundació Institut d'Investigació en Ciències de la

HEMATOLOGIA I
HEMOTERÀPIA
Publicacions
Factor d’impacte total: 130,108
Alvarez-Larran, A; Cervantes, F; Pereira, A; Arellano-Rodrigo, E; Perez-Andreu, V; Hernandez-Boluda, JC;
Ayats, R;
Salvador, C; Muntanola, A; Bellosillo, B; Vicente, V; Hernandez-Nieto, L; Burgaleta, C; Xicoy, B; Besses, C
Observation versus antiplatelet therapy as primary prophylaxis for thrombosis in low-risk essential
thrombocythemia
BLOOD 2010 Aug 26;116(8):1205-10; quiz 1387. Epub 2010 May 27.
IF: 10,558
Brüggemann M, Schrauder A, Raff T, Pfeifer H, Dworzak M, Ottmann OG, Asnafi V, Baruchel A, Bassan R,
Benoit Y, Biondi A, Cavé H, Dombret H, Fielding AK, Foà R, Gökbuget N, Goldstone AH, Goulden N, Henze
G, Hoelzer D, Janka-Schaub GE, Macintyre EA, Pieters R, Rambaldi A, Ribera JM, Schmiegelow K, Spinelli
O, Stary J, von Stackelberg A, Kneba M, Schrappe M, van Dongen JJ.
Standardized MRD quantification in European ALL trials: Proceedings of the Second International
Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008.
LEUKEMIA 2010 Mar;24(3):521-35. Epub 2009 Dec 24.
IF: 8,966
E Carreras, L Rosiñol, MJ Terol, A Alegre, F de Arriba, J García-Laraña, JL Bello, R García, A León, R
Martínez, MJ Peñarrubia, C Poderós, P Ribas, JM Ribera, JF San Miguel, J Bladé, JJ Lahuerta
Veno-occlusive disease of the liver after high-dose cytoreductive therapy with busulfan and melphalan
for autologous blood stem-cell transplantation in multiple myeloma patients.
BIOL BLOOD MARROW TR
IF: 3,275
Espinet, B; Salaverria, I; Bea, S; Ruiz-Xiville, N; Balague, O; Salido, M; Costa, D; Carreras, J; Rodriguez-
Vicente, AE; Garcia, JL; Hernandez-Rivas, JM; Calasanz, MJ; Siebert, R; Ferrer, A; Salar, A; Carrio, A; Polo,
N; Garcia-Marco, JA; Domingo, A; Gonzalez-Barca, E; Romagosa, V; Marugan, I; Lopez-Guillermo, A;
Milla, F; Mate, JL; Luno, E; Sanzo, C; Collado, R; Oliver, I; Monzo, S; Palacin, A; Gonzalez, T; Sant, F;
Salinas, R; Ardanaz, MT; Font, L; Escoda, L; Florensa, L; Serrano, S; Campo, E; Sole, F
Incidence and Prognostic Impact of Secondary Cytogenetic Aberrations in a Series of 145 Patients with
Mantle Cell Lymphoma.
GENE CHROMOSOME CANC 2010; MAY, 49 (5) 439-451
IF: 3,99
Ferra, C; Sanz, J; de la Camara, R; Sanz, G; Bermudez, A; Valcarcel, D; Rovira, M; Serrano, D; Caballero, D;
Espigado, I; Morgades, M; Heras, I; Solano, C; Duarte, R; Barrenetxea, C; Garcia-Noblejas, A; Diez-Martin,
JL; Iriondo, A; Carreras, E; Sierra, J; Sanz, MA; Ribera, JM
Unrelated Transplantation for Poor-Prognosis Adult Acute Lymphoblastic Leukemia: Long-Term
Outcome Analysis and Study of the Impact of Hematopoietic Graft Source
BIOL BLOOD MARROW TR 2010 Jul;16(7):957-66. Epub 2010 Feb 7.
IF: 3,275
Giebel S, Stella-Holowiecka B, Krawczyk-Kulis M, Gökbuget N, Hoelzer D, Doubek M, Mayer J,
Pàgina 63 de 148